Anthem (Indiana, converted) acquired Trigon (Virginia, converted) in 2002
Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonism: This component acts synergistically with GLP-1
The AP densely co-expresses the GIPR and the GLP-1R, enabling it to directly receive and integrate dual hormonal signals from the systemic circulation
When the GLP-1 receptor is activated across these systems, several metabolic processes occur: Improved insulin sensitivity Better glucose uptake by cells Reduced excessive glucagon production Enhanced satiety signaling to the brain More stable energy levels after meals Together, these changes create a metabolic environment that supports efficient energy usage rather than excess energy storage
If you need to continue on the program simply book another virtual visit to check in and refill
When that pathway is disrupted by obesity, aging, or poor diet GLP-1 production downstream suffers